Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.55 |
| ▸ | CCR5 | P51681 | 3/20 | 0.55 |
| ▸ | CCR8 | P51685 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | METAP1 | P53582 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31517145 | 1.00 | CCR1 (0.55) | CCR1CCR5CCR8TP53PKM | |
| Hydrochloric Acid SCHEMBL9225985 | 0.98 | CCR1 (0.53) | CCR1CCR5CCR8TP53PKM | |
| SCHEMBL30074397 | 0.98 | CCR1 (0.53) | CCR1CCR5CCR8TP53PKM | |
| SCHEMBL2986171 | 0.94 | MEN1 (0.60) | CCR1CCR5CCR8TP53PKM | |
| SCHEMBL23609564 | 0.94 | TP53 (0.52) | CCR1CCR5CCR8TP53PKM | |
| SCHEMBL22761519 | 0.91 | CCR1 (0.50) | CCR1CCR5CCR8TP53PKM | |
| SCHEMBL2007559 | 0.91 | CCR1 (0.64) | CCR1CCR5CCR8TP53PKM | |
| SCHEMBL13311187 | 0.91 | CCR1 (0.64) | CCR1CCR5CCR8TP53PKM | |
| SCHEMBL29660049 | 0.91 | CCR1 (0.64) | CCR1CCR5CCR8TP53PKM | |
| 2-Mercaptopyridine SCHEMBL7790665 | 0.89 | TP53 (0.46) | CCR1CCR5CCR8TP53PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105734059-A | GP73 inhibitor and application thereof | 中国医学科学院基础医学研究所 | 2016-07-06 | — | — | CN | claimed |
| CN-102965099-B | Novel rare earth/terpyridyl functionalized ionic liquid luminescent material | UNIV HEBEI TECHNOLOGY | 2014-06-11 | — | — | CN | claimed |
| WO-2026042469-A1 | CURABLE COMPOSITION FOR THREE-DIMENSIONAL STEREOLITHOGRAPHY, METHOD FOR PRODUCING OBJECT BY THREE-DIMENSIONAL STEREOLITHOGRAPHY, AND METHOD FOR PRODUCING DENTAL RESTORATION | 株式会社トクヤマデンタル | 2026-02-26 | — | — | WO | disclosed |
| CN-118972914-A | Different system switching method and terminal | 荣耀终端有限公司 | 2024-11-15 | — | — | CN | disclosed |
| US-20240203603-A1 | HEALTH MANAGEMENT METHOD, SYSTEM, AND ELECTRONIC DEVICE | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2024-06-20 | — | — | US | disclosed |
| US-20240180788-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | TOKUYAMA DENTAL CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| WO-2024106666-A1 | METHOD FOR SYNTHESIZING AND PREPARING ORGANOBORON COMPOUND BY USING NICKEL CATALYSIS | 울산과학기술원 | 2024-05-23 | — | — | WO | disclosed |
| EP-4369357-A1 | HEALTH MANAGEMENT METHOD AND SYSTEM, AND ELECTRONIC DEVICE | Huawei Technologies Co., Ltd. (CN) | 2024-05-15 | — | — | EP | disclosed |
| EP-4310128-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | Tokuyama Dental Corporation (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-11844272-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| CN-116112466-A | Domain name resolution method and device | 阿里巴巴（中国）有限公司 | 2023-05-12 | — | — | CN | disclosed |
| US-20040251466-A1 | Electron injection composition for light emitting element, light emitting element, and light emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| US-20040142843-A1 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORP. | 2004-07-22 | — | — | US | disclosed |
| WO-2004039933-A1 | USE OF METAL COMPLEX COMPOUNDS AS CATALYSTS FOR OXIDATION USING MOLECULAR OXYGEN OR AIR | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-05-13 | — | — | WO | disclosed |
| EP-0983282-B1 | METAL COMPLEX PHOTOSENSITIZER AND PHOTOVOLTAIC CELL | ECOLE POLYTECH (CH) | 2003-11-12 | — | — | EP | disclosed |
| US-6245988-B1 | USEFUL IN A PHOTOVOLTAIC CELL COMPRISING A NANOCRYSTALLINE TITANIUM DIOXIDE LAYER; IMPROVING THE EFFICIENCY OF SOLAR TO ELECTRIC POWER CONVERSION BY PROVIDING PHOTOSENSITIZER HAVING ENHANCED SPECTRAL RESPONSE IN RED/INFRARED REGIONS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2001-06-12 | — | — | US | disclosed |
| WO-2001007497-A2 | PERFORMANCE OF ENERGY STORAGE DEVICES: POTENTIAL AREAS FOR DENDRITIC CHEMISTRY INVOLVEMENT | UNIVERSITY OF SOUTH FLORIDA (US) | 2001-02-01 | — | — | WO | disclosed |
| EP-0983282-A1 | METAL COMPLEX PHOTOSENSITIZER AND PHOTOVOLTAIC CELL | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2000-03-08 | — | — | EP | disclosed |
| WO-1998050393-A1 | METAL COMPLEX PHOTOSENSITIZER AND PHOTOVOLTAIC CELL | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 1998-11-12 | — | — | WO | disclosed |
| EP-0677293-A1 | PHARMACEUTICAL USE OF TERPYRIDINE DERIVATIVE | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1995-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240180788-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | CRY1, CRY2, TYR | CCR1 2837/4885CCR5 3479/4885CCR8 4149/4885 |
| US-11844272-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | PIEZO1, LEF1, ODC1 | CCR1 1080/4885CCR5 2936/4885CCR8 2591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.